Skip to main content
. Author manuscript; available in PMC: 2021 Sep 25.
Published in final edited form as: Psychooncology. 2021 Jan 2;30(5):708–715. doi: 10.1002/pon.5616

Table 1.

Demographic and clinical characteristics of rural and urban HNC patients at diagnosis

Rural N = 192 (42.3%) Urban N = 262 (57.7%) p-value
Sex .43
 Male 125 (65.1%) 161 (61.5%)
 Female 67 (34.9%) 101 (38.5%)
Age .55
 Mean (SD) 60.9 (12.3) 60.2 (12.4)
Race .17
 White 187 (97.4%) 252 (96.1%)
 Black 1 (<1%) 7 (2.7%)
 Other 4 (2.1%) 3 (1.1%)
Stage .54
 Early (0–2) 74 (38.5%) 97 (37.0%)
 Advanced (3–4) 106 (55.2%) 144 (55.0%)
 Not stageable/unknown 12 (6.2%) 21 (8.0%)
Site .09
 Oral cavity 72 (37.5%) 117 (44.6%)
 Oropharynx 39 (20.3%) 57 (21.7%)
 Hypopharynx 7 (3.6%) 12 (4.6%)
 Larynx 45 (23.4%) 35 (13.4%)
 Else/unknown 29 (15.1%) 41 (15.6%)
Treatment .78
 Surgery only 70 (36.5%) 97 (37.0%)
 Chemotherapy only 0 (0%) 1 (<1%)
 Radiotherapy only 23 (12.0%) 22 (8.4%)
 Combination 84 (43.7%) 118 (45.0%)
 Other/unknown 15 (7.8%) 24 (9.2%)
Smoking status .43
 Current 57 (29.7%) 67 (25.6%)
 Previous 91 (47.4%) 126 (48.1%)
 Never 44 (22.9%) 69 (26.3%)
Drinking status .21
 Current 106 (55.2%) 160 (61.0%)
 Previous 86 (44.8%) 102 (38.9%)
SMAST score (Mean/SD/95% CI) 2.07 (2.95); 1.65–2.49 1.51 (2.66); 1.19–1.84 .03
SMAST score .01
 0–1 116 (60.4%) 193 (73.6%)
 2 29 (15.1%) 18 (6.9%)
 3+ 47 (24.5%) 51 (19.5%)
BDI score (Mean/SD/95% CI) 8.5 (7.6); 7.5–9.4 8.3 (6.6); 7.6–9.0 .77
 Minimal (0–9) 124 (64.6) 172 (65.6) .93
 Mild (10–18) 55 (28.6) 76 (29.0)
 Moderate (19–29) 9 (4.7) 10 (3.8)
 Severe (30+) 4 (2.1) 4 (1.5)
HNCI scores (Mean/SD/95% CI)
 Aesthetics 87.5 (21.4); 84.6–90.5 85.7 (24.6); 82.9–88.4 .42
 Eating 71.4 (25.8); 68.1–74.7 70.7 (25.0); 67.9–73.5 .77
 Speech 74.3 (23.1); 71.2–77.4 77.5 (22.2); 75.0–80.0 .14
 Social Disruption 80.5 (21.0); 77.8–83.3 82.0 (19.6); 79.8–84.2 .39

Note: T-tests and chi-square test used as appropriate.